Tower Research Capital LLC (TRC) - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 102 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$101,209
+8.8%
16,324
+65.7%
0.00%0.0%
Q1 2024$92,993
+276.6%
9,851
+169.3%
0.00%
Q4 2023$24,692
+6.0%
3,658
-30.3%
0.00%
-100.0%
Q3 2023$23,297
-35.9%
5,247
-52.4%
0.00%0.0%
Q2 2023$36,366
+213817.6%
11,020
+86.1%
0.00%0.0%
Q1 2023$17
+30.8%
5,920
+224.6%
0.00%0.0%
Q4 2022$13
-99.9%
1,824
-13.7%
0.00%
Q3 2022$17,000
-39.3%
2,113
-64.2%
0.00%
-100.0%
Q2 2022$28,000
+75.0%
5,903
+789.0%
0.00%
Q1 2022$16,000
-75.4%
664
-81.7%
0.00%
-100.0%
Q4 2021$65,000
+333.3%
3,627
+579.2%
0.00%
Q3 2021$15,000
-11.8%
534
-67.7%
0.00%
Q2 2021$17,000
+41.7%
1,653
+62.1%
0.00%
Q1 2021$12,000
-80.3%
1,020
-80.4%
0.00%
-100.0%
Q4 2020$61,000
-43.0%
5,199
-61.6%
0.00%
+100.0%
Q3 2020$107,000
+137.8%
13,555
+448.6%
0.00%
-50.0%
Q2 2020$45,000
+650.0%
2,471
+165.4%
0.00%
Q3 2019$6,0009310.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$70,091,00017.54%
TRV GP IV, LLC 2,343,154$41,450,00011.92%
ACUTA CAPITAL PARTNERS, LLC 200,000$3,538,0001.49%
HighVista Strategies LLC 89,963$1,591,0001.27%
Logos Global Management LP 685,000$12,118,0001.25%
Monashee Investment Management LLC 273,045$4,830,0001.19%
RTW INVESTMENTS, LP 3,866,872$68,405,0001.00%
Parkman Healthcare Partners LLC 250,106$4,424,0000.98%
Deep Track Capital, LP 750,000$13,268,0000.94%
Darwin Global Management, Ltd. 317,428$5,615,0000.86%
View complete list of FULCRUM THERAPEUTICS INC shareholders